Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

CryoLife and Viragen enter cancer therapy collaboration

March 3, 2000

IL-4 gene therapy studied in malignant glioma

March 3, 2000

Maxygen enters CRADA with NCI for anticancer proteins

March 2, 2000

Several new approvals obtained for Gliadel

March 2, 2000

Feasibility of HSV-TK/GCV gene therapy demonstrated in glioblastoma multiforme

March 2, 2000

Aptosyn/Gemzar cancer trials to begin shortly

March 2, 2000

VEGF-targeted antisense oligonucleotides inhibit tumor growth

March 2, 2000

AstraZeneca files sNDA with FDA for Casodex 150 mg

March 1, 2000

Alimta, a multitargeted antifolate: clinical experience outlined at ICACT

March 1, 2000

Phase I results support further evaluation of i.v. R-101933 + paclitaxel

March 1, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...